The UT Institutional Biosafety Committee (IBC) meets once a month to review registrations and discuss compliance issues involving biological safety on campus.

The IBC is responsible for the review and approval of research protocols involving:

• Recombinant or synthetic nucleic acid molecules
• Biological agents (bacteria, viruses, fungi, protozoa, and prions)
• Acute toxins of biological origin
• Human or nonhuman primate blood, blood products, tissues, secretions, excretions, or cell lines*
• Venomous animals
• Poisonous plants
• Novel nanoparticles
• Diagnostic specimens or environmental samples

* Research use of all agents infectious to humans must be registered with the IBC. Agents infectious to animals or plants must be registered with the IBC if federal agency permits are required for the possession or use of these agents.

This meeting is open to the public.

Amendments, MTAs, and new registrations should be submitted a month before the meeting to be considered for review. Submissions should be made via the Safety Stratus Biosafety Module. (For more information, go to the EHS Safety Stratus page at https://ehs.utk.edu/index.php/safety-stratus/.) Submission and prior approval of IBC protocols does not mean future approval. Please allow ample time for the committee to perform an appropriate risk assessment.